GSWM
TGTX icon

Golden State Wealth Management’s TG Therapeutics TGTX Stock Holding History

Golden State Wealth Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.8K Hold
433
– – ﹤0.01% 916
2026
Q1 		$14.4K Hold
433
– – ﹤0.01% 997
2025
Q4 		$12.9K Hold
433
– – ﹤0.01% 1035
2025
Q3 		$15.6K Hold
433
– – ﹤0.01% 977
2025
Q2 		$15.6K Hold
433
– – ﹤0.01% 948
2025
Q1 		$17.1K Hold
433
– – ﹤0.01% 842
2024
Q4 		$13K Buy
+433
New +$12.4K ﹤0.01% 887

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Golden State Wealth Management's TGTX Position: Q2 2026 in Review

Golden State Wealth Management held its TG Therapeutics (TGTX) position steady in Q2 2026 at 433 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #916.

Golden State Wealth Management first reported a position in TGTX in Q4 2024 and has held it in 7 quarters since. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Golden State Wealth Management held 433 shares of TG Therapeutics worth $23.8K as of Q2 2026.
  • Golden State Wealth Management left its TG Therapeutics share count unchanged in Q2 2026.
  • TG Therapeutics made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #916 holding.
  • Golden State Wealth Management first reported a position in TG Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.